sampleID	_EVENT	_INTEGRATION	OS.time	OS	OS.unit	_PATIENT	_TIME_TO_EVENT	_TIME_TO_EVENT_UNIT	_cohort	_primary_disease	_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	age_at_initial_pathologic_diagnosis	albumin_result_lower_limit	albumin_result_specified_value	albumin_result_upper_limit	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	bilirubin_lower_limit	bilirubin_upper_limit	ca_19_9_level	ca_19_9_level_lower	ca_19_9_level_upper	cancer_first_degree_relative	child_pugh_classification_grade	cholangitis_tissue_evidence	creatinine_lower_level	creatinine_upper_limit	creatinine_value_in_mg_dl	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_after_initial_treatment	eastern_cancer_oncology_group	family_cancer_type_txt	family_member_relationship_type	fetoprotein_outcome_lower_limit	fetoprotein_outcome_upper_limit	fetoprotein_outcome_value	fibrosis_ishak_score	form_completion_date	gender	height	hist_hepato_carc_fact	hist_hepato_carcinoma_risk	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	initial_weight	inter_norm_ratio_lower_limit	intern_norm_ratio_upper_limit	is_ffpe	lost_follow_up	neoplasm_histologic_grade	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_tumor_event_ablation_embo_tx	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	new_tumor_event_liver_transplant	oct_embedded	other_dx	pathologic_M	pathologic_N	pathologic_T	pathologic_stage	pathology_report_file_name	patient_id	perineural_invasion_present	person_neoplasm_cancer_status	platelet_result_count	platelet_result_lower_limit	platelet_result_upper_limit	post_op_ablation_embolization_tx	postoperative_rx_tx	prothrombin_time_result_value	radiation_therapy	relative_family_cancer_history	residual_tumor	sample_type	sample_type_id	specimen_collection_method_name	system_version	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	total_bilirubin_upper_limit	tumor_tissue_site	vascular_tumor_cell_type	vial_number	vital_status	weight	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_CHOL_mutation_broad_gene	_GENOMIC_ID_TCGA_CHOL_mutation_bcgsc_gene	_GENOMIC_ID_TCGA_CHOL_hMethyl450	_GENOMIC_ID_TCGA_CHOL_exp_HiSeqV2	_GENOMIC_ID_TCGA_CHOL_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_CHOL_mutation_bcm_gene	_GENOMIC_ID_TCGA_CHOL_miRNA_HiSeq	_GENOMIC_ID_TCGA_CHOL_gistic2thd	_GENOMIC_ID_TCGA_CHOL_gistic2	_GENOMIC_ID_TCGA_CHOL_PDMRNAseqCNV	_GENOMIC_ID_TCGA_CHOL_exp_HiSeqV2_exon	_GENOMIC_ID_data/public/TCGA/CHOL/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_CHOL_mutation_ucsc_maf_gene	_GENOMIC_ID_TCGA_CHOL_PDMRNAseq	_GENOMIC_ID_TCGA_CHOL_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_CHOL_RPPA
TCGA-3X-AAV9-01	1	TCGA-3X-AAV9-01	339	1	days	TCGA-3X-AAV9	339	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			72	3.3	2.7	4.8		TCGA-3X-AAV9	TCGA-3X-AAV9-01A	0	0.2	538	0	35	2	B	None	0.6	1.4	1.1	-26349	1113	339	0			0	|Probably Kidney Cancer	Brother|Brother				0 - No Fibrosis	2014-7-9	MALE	169	Ulcerative colitis		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	740			NO		G2					YES		true	Yes	M0	N0	T1	Stage I	TCGA-3X-AAV9.3E7DD345-7A2C-4D7B-B5A2-2207949186CA.pdf	AAV9	YES	WITH TUMOR	254	150	400	NO	YES		NO	YES	R0	Primary Tumor	01	Other (specify)	7th	YES	NO	3X	1.4	Bile duct	None	A	DECEASED	52	2010	TCGA-3X-AAV9-01A-72D-A417-09	TCGA-3X-AAV9-01A-72D-A417-09	TCGA-3X-AAV9-01A-72D-A418-05	59012a78-0e8f-4b99-af97-0dbb1d3d0513	59012a78-0e8f-4b99-af97-0dbb1d3d0513	TCGA-3X-AAV9-01A-72D-A417-09	TCGA-3X-AAV9-01	TCGA-3X-AAV9-01A-72D-A416-01	TCGA-3X-AAV9-01A-72D-A416-01	TCGA-3X-AAV9-01	59012a78-0e8f-4b99-af97-0dbb1d3d0513	TCGA-3X-AAV9-01	TCGA-3X-AAV9-01A-72D-A417-09	TCGA-3X-AAV9-01	59012a78-0e8f-4b99-af97-0dbb1d3d0513	AEB48F2C-59ED-45B1-BC10-1875590E7C47
TCGA-3X-AAVA-01	1	TCGA-3X-AAVA-01	445	1	days	TCGA-3X-AAVA	445	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			50					TCGA-3X-AAVA	TCGA-3X-AAVA-01A			8					None	0.4	1.1	0.5	-18303	510	445	0			1			0	10	5.4	1,2 - Portal Fibrosis	2014-9-2	FEMALE		Diabetes mellitus|Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	480			NO		G2					YES		true	No	M0	NX	T2b	Stage II	TCGA-3X-AAVA.4C9A220D-03E9-41CF-8FA9-4B7FD05A625A.pdf	AAVA	YES	WITH TUMOR	214	150	400	NO	NO		NO	NO	R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	3X		Bile duct	None	A	DECEASED	92	2012	TCGA-3X-AAVA-01A-11D-A417-09	TCGA-3X-AAVA-01A-11D-A417-09	TCGA-3X-AAVA-01A-11D-A418-05	6a8ffc5d-444e-4864-bafd-ddf1ef900ef0	6a8ffc5d-444e-4864-bafd-ddf1ef900ef0	TCGA-3X-AAVA-01A-11D-A417-09	TCGA-3X-AAVA-01	TCGA-3X-AAVA-01A-11D-A416-01	TCGA-3X-AAVA-01A-11D-A416-01	TCGA-3X-AAVA-01	6a8ffc5d-444e-4864-bafd-ddf1ef900ef0	TCGA-3X-AAVA-01	TCGA-3X-AAVA-01A-11D-A417-09	TCGA-3X-AAVA-01	6a8ffc5d-444e-4864-bafd-ddf1ef900ef0	51164357-1D61-4499-82ED-169A9DA8A4C0
TCGA-3X-AAVB-01	0	TCGA-3X-AAVB-01	402	0	days	TCGA-3X-AAVB	402	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			70	3.3	4.3	4.8	TCGA-3X-AAVB-F67237	TCGA-3X-AAVB	TCGA-3X-AAVB-01A	0	1.7	322	0	35		A	None	0.4	1.1	0.9	-25819	386		0	402		0							2014-11-3	FEMALE	170	No History of Primary Risk Factors		Cholangiocarcinoma; distal	No	C24.0	8160/3	C24.0	YES	420	0.9	1.1	NO	NO	G1							true	No	M1	N1	T3	Stage IVB	TCGA-3X-AAVB.BEA4C577-73ED-48F0-9417-AA8BD143B5C8.pdf	AAVB	YES		215	150	400			1.1		NO	R0	Primary Tumor	01	Pancreaticoduodenectomy (Whipple Resection)	7th	NO	YES	3X	1.2	Bile duct	None	A	LIVING	76	2012	TCGA-3X-AAVB-01A-31D-A417-09	TCGA-3X-AAVB-01A-31D-A417-09	TCGA-3X-AAVB-01A-31D-A418-05	88336d42-a31c-448f-a077-2608786c80fe	88336d42-a31c-448f-a077-2608786c80fe	TCGA-3X-AAVB-01A-31D-A417-09	TCGA-3X-AAVB-01	TCGA-3X-AAVB-01A-31D-A416-01	TCGA-3X-AAVB-01A-31D-A416-01	TCGA-3X-AAVB-01	88336d42-a31c-448f-a077-2608786c80fe	TCGA-3X-AAVB-01	TCGA-3X-AAVB-01A-31D-A417-09	TCGA-3X-AAVB-01	88336d42-a31c-448f-a077-2608786c80fe	
TCGA-3X-AAVC-01	0	TCGA-3X-AAVC-01	709	0	days	TCGA-3X-AAVC	709	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			72	3.3	2.4	4.8	TCGA-3X-AAVC-F67116	TCGA-3X-AAVC	TCGA-3X-AAVC-01A	0	0.5					B	None	0.4	1.1	0.8	-26493	428		0	709		0						1,2 - Portal Fibrosis	2014-10-30	FEMALE	159	Other	Pancreatitis	Cholangiocarcinoma; hilar/perihilar	No	C24.0	8160/3	C24.0	YES	230	0.9	1.1	NO	NO	G3					NO		true	No	M0	N0	T1	Stage I	TCGA-3X-AAVC.88206A8B-257B-4C0F-B42C-905DEA9483FB.pdf	AAVC	NO	TUMOR FREE	255	150	400	NO	NO	1.1	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	3X	1.2	Bile duct	None	A	LIVING	104	2012	TCGA-3X-AAVC-01A-21D-A417-09	TCGA-3X-AAVC-01A-21D-A417-09	TCGA-3X-AAVC-01A-21D-A418-05	8c8d5e98-023b-4496-a237-2632c609f627	8c8d5e98-023b-4496-a237-2632c609f627	TCGA-3X-AAVC-01A-21D-A417-09	TCGA-3X-AAVC-01	TCGA-3X-AAVC-01A-21D-A416-01	TCGA-3X-AAVC-01A-21D-A416-01	TCGA-3X-AAVC-01	8c8d5e98-023b-4496-a237-2632c609f627	TCGA-3X-AAVC-01	TCGA-3X-AAVC-01A-21D-A417-09	TCGA-3X-AAVC-01	8c8d5e98-023b-4496-a237-2632c609f627	D423C8E5-02C2-445A-BA13-C74C0012E2B4
TCGA-3X-AAVE-01	0	TCGA-3X-AAVE-01	650	0	days	TCGA-3X-AAVE	650	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			60	3.3	4	4.8	TCGA-3X-AAVE-F72744	TCGA-3X-AAVE		0	1					A	None	0.6	1.4	0.9	-21943			0	650		0			0	10	3.6	3,4 - Fibrous Speta	2015-11-24	MALE	160	Hepatitis B|Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES		0.9	1.1		NO	G2					NO			No	M0	N0	T2	Stage II		AAVE	NO	TUMOR FREE	233	150	400	NO	NO	0.9	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	3X	1.4	Bile duct	Micro		LIVING	59	2013	TCGA-3X-AAVE-01A-11D-A417-09	TCGA-3X-AAVE-01A-11D-A417-09	TCGA-3X-AAVE-01A-11D-A418-05	c49a7f2a-f7ef-419d-829a-0b3a9f915aad	c49a7f2a-f7ef-419d-829a-0b3a9f915aad	TCGA-3X-AAVE-01A-11D-A417-09	TCGA-3X-AAVE-01	TCGA-3X-AAVE-01A-11D-A416-01	TCGA-3X-AAVE-01A-11D-A416-01	TCGA-3X-AAVE-01	c49a7f2a-f7ef-419d-829a-0b3a9f915aad	TCGA-3X-AAVE-01	TCGA-3X-AAVE-01A-11D-A417-09	TCGA-3X-AAVE-01	c49a7f2a-f7ef-419d-829a-0b3a9f915aad	
TCGA-4G-AAZO-01	0	TCGA-4G-AAZO-01	1177	0	days	TCGA-4G-AAZO	1177	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			71	3.4	3.8	4.8	TCGA-4G-AAZO-F72742	TCGA-4G-AAZO		0.3	0.7	6	0	35.0			None	0.6	1.1	0.9	-25989			0	1177		1			0	9.0	2.4	1,2 - Portal Fibrosis	2015-12-10	FEMALE	161	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES		10	13		NO	G2					YES			No	M0	N0	T2a	Stage II		AAZO	NO	WITH TUMOR	164000	140000	450000	NO	YES	11.6	NO	NO	R1	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	4G	1.2	Bile duct	None		LIVING	67	2012	TCGA-4G-AAZO-01A-12D-A417-09	TCGA-4G-AAZO-01A-12D-A417-09	TCGA-4G-AAZO-01A-12D-A418-05	f36ef26a-5c56-422b-bcdf-4693615d026b	f36ef26a-5c56-422b-bcdf-4693615d026b	TCGA-4G-AAZO-01A-12D-A417-09	TCGA-4G-AAZO-01	TCGA-4G-AAZO-01A-12D-A416-01	TCGA-4G-AAZO-01A-12D-A416-01	TCGA-4G-AAZO-01	f36ef26a-5c56-422b-bcdf-4693615d026b	TCGA-4G-AAZO-01	TCGA-4G-AAZO-01A-12D-A417-09	TCGA-4G-AAZO-01	f36ef26a-5c56-422b-bcdf-4693615d026b	
TCGA-4G-AAZT-01	0	TCGA-4G-AAZT-01	420	0	days	TCGA-4G-AAZT	420	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			62	3.4	4.4	4.8	TCGA-4G-AAZT-F72743	TCGA-4G-AAZT	TCGA-4G-AAZT-01A	0.3	0.6	52.8	0	35.0			None	0.6	1.1	0.6	-22777	45		0	420		0			0	9.0	2	1,2 - Portal Fibrosis	2015-11-24	MALE	175	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	330	10	13	NO	NO	G2					NO		false	No	M0	N0	T1	Stage I	TCGA-4G-AAZT.C75C91FD-D4DE-4A58-A4C7-8F020AAC59EB.pdf	AAZT	NO	TUMOR FREE	354000	140000	450000	NO	NO	11.7	NO	NO	R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	4G	1.2	Bile duct	None	A	LIVING	65	2013	TCGA-4G-AAZT-01A-11D-A417-09	TCGA-4G-AAZT-01A-11D-A417-09	TCGA-4G-AAZT-01A-11D-A418-05	355d81ff-9689-4301-bd41-3df7403b533c	355d81ff-9689-4301-bd41-3df7403b533c	TCGA-4G-AAZT-01A-11D-A417-09	TCGA-4G-AAZT-01	TCGA-4G-AAZT-01A-11D-A416-01	TCGA-4G-AAZT-01A-11D-A416-01	TCGA-4G-AAZT-01	355d81ff-9689-4301-bd41-3df7403b533c	TCGA-4G-AAZT-01	TCGA-4G-AAZT-01A-11D-A417-09	TCGA-4G-AAZT-01	355d81ff-9689-4301-bd41-3df7403b533c	3580629A-CE72-4A05-9811-5347E590A68B
TCGA-W5-AA2G-01	0	TCGA-W5-AA2G-01	1976	0	days	TCGA-W5-AA2G	1976	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			62	3.5	4.1	5.0	TCGA-W5-AA2G-F66604	TCGA-W5-AA2G	TCGA-W5-AA2G-01A	0.1	0.7	71	0	55	1	A	None	0.6	1.1	0.7	-22933	2087		0	1976		1	Testicular|Prostate|Leukemia	Father|Father|Father	0	6.0	2.5	0 - No Fibrosis	2014-10-21	FEMALE	159	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	250	0.8	1.2	NO	YES	G3					NO		true	No	M0	N0	T1	Stage I	TCGA-W5-AA2G.1E7EDF0B-283F-44F9-A89A-83DB12A0D58A.pdf	AA2G	NO	TUMOR FREE	159	150	450	NO	NO	1.2	NO	YES	R0	Primary Tumor	01	Extended Lobectomy	7th	NO	YES	W5	1.0	Bile duct	None	A	LIVING	52	2008	TCGA-W5-AA2G-01A-11D-A417-09	TCGA-W5-AA2G-01A-11D-A417-09	TCGA-W5-AA2G-01A-11D-A418-05	0431cd43-2dd6-4319-8017-6ed8b8e77dc0	0431cd43-2dd6-4319-8017-6ed8b8e77dc0	TCGA-W5-AA2G-01A-11D-A417-09	TCGA-W5-AA2G-01	TCGA-W5-AA2G-01A-11D-A416-01	TCGA-W5-AA2G-01A-11D-A416-01	TCGA-W5-AA2G-01	0431cd43-2dd6-4319-8017-6ed8b8e77dc0	TCGA-W5-AA2G-01	TCGA-W5-AA2G-01A-11D-A417-09	TCGA-W5-AA2G-01	0431cd43-2dd6-4319-8017-6ed8b8e77dc0	936F1B55-9593-4BCF-ADEF-F9F96D092DD5
TCGA-W5-AA2H-01	0	TCGA-W5-AA2H-01	1077	0	days	TCGA-W5-AA2H	1077	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			70	3.5	4.3	5.0	TCGA-W5-AA2H-F72736	TCGA-W5-AA2H	TCGA-W5-AA2H-01A	0.1	1.2	44	0	55	2	A	None	0.6	1.1	0.9	-25775	474		0	1077		0	colon/rectal cancer|lung	Father|Sister	0	6.0	3.1	0 - No Fibrosis	2015-11-23	FEMALE	162	No History of Primary Risk Factors		Cholangiocarcinoma; distal	No	C22.1	8160/3	C22.1	YES	180	0.8	1.2	NO	NO	G3					NO		true	No	M0	N0	T3	Stage III	TCGA-W5-AA2H.46A92484-5ECB-4F04-9207-4188D015B9CD.pdf	AA2H	NO	TUMOR FREE	369	150	450	NO	YES	0.9	NO	YES	R0	Primary Tumor	01	Pancreaticoduodenectomy (Whipple Resection)	7th	NO	YES	W5	1.0	Bile duct	None	A	LIVING	71	2012	TCGA-W5-AA2H-01A-31D-A417-09	TCGA-W5-AA2H-01A-31D-A417-09	TCGA-W5-AA2H-01A-31D-A418-05	b0ada585-0834-406b-b02c-b06c171882ff	b0ada585-0834-406b-b02c-b06c171882ff	TCGA-W5-AA2H-01A-31D-A417-09	TCGA-W5-AA2H-01	TCGA-W5-AA2H-01A-31D-A416-01	TCGA-W5-AA2H-01A-31D-A416-01	TCGA-W5-AA2H-01	b0ada585-0834-406b-b02c-b06c171882ff	TCGA-W5-AA2H-01	TCGA-W5-AA2H-01A-31D-A417-09	TCGA-W5-AA2H-01	b0ada585-0834-406b-b02c-b06c171882ff	B2998B9E-3F52-416C-80A2-87B1A3B0860D
TCGA-W5-AA2I-01	1	TCGA-W5-AA2I-01	1939	1	days	TCGA-W5-AA2I	1939	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			66	3.5	4.4	5.0		TCGA-W5-AA2I	TCGA-W5-AA2I-01A	0.1	0.7	296	0	40		A	None	0.9	1.4	1.4	-24388	3131	1939	0			0			0	6.0	2.9	0 - No Fibrosis	2014-5-22	MALE	178	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	280	0.9	1.2	NO		G2					YES		true	No	M0	N0	T1	Stage I	TCGA-W5-AA2I.7C977B78-0280-4078-BA64-4D8D9554B38F.pdf	AA2I	NO	WITH TUMOR	138	150	450	NO	NO	1.1	NO	NO	R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	W5	1.0	Bile duct	None	A	DECEASED	125	2005	TCGA-W5-AA2I-01A-32D-A417-09	TCGA-W5-AA2I-01A-32D-A417-09	TCGA-W5-AA2I-01A-32D-A418-05	51dfbd25-fa30-4ac5-b375-fde6ddbaa151	51dfbd25-fa30-4ac5-b375-fde6ddbaa151	TCGA-W5-AA2I-01A-32D-A417-09	TCGA-W5-AA2I-01	TCGA-W5-AA2I-01A-32D-A416-01	TCGA-W5-AA2I-01A-32D-A416-01	TCGA-W5-AA2I-01	51dfbd25-fa30-4ac5-b375-fde6ddbaa151	TCGA-W5-AA2I-01	TCGA-W5-AA2I-01A-32D-A417-09	TCGA-W5-AA2I-01	51dfbd25-fa30-4ac5-b375-fde6ddbaa151	C5E92850-7441-47DB-8512-FE6A49708548
TCGA-W5-AA2I-11	1	TCGA-W5-AA2I-11	1939	1	days	TCGA-W5-AA2I	1939	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			66	3.5	4.4	5.0		TCGA-W5-AA2I		0.1	0.7	296	0	40		A	None	0.9	1.4	1.4	-24388		1939	0			0			0	6.0	2.9	0 - No Fibrosis	2014-5-22	MALE	178	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES		0.9	1.2			G2					YES			No	M0	N0	T1	Stage I		AA2I	NO	WITH TUMOR	138	150	450	NO	NO	1.1	NO	NO	R0	Solid Tissue Normal	11	Segmentectomy, Multiple	6th	NO	YES	W5	1.0	Bile duct	None		DECEASED	125	2005			TCGA-W5-AA2I-11A-11D-A418-05	a8aea83d-802a-48b3-aea2-65e78fefc9b0	a8aea83d-802a-48b3-aea2-65e78fefc9b0		TCGA-W5-AA2I-11				a8aea83d-802a-48b3-aea2-65e78fefc9b0	TCGA-W5-AA2I-11			a8aea83d-802a-48b3-aea2-65e78fefc9b0	
TCGA-W5-AA2O-01	1	TCGA-W5-AA2O-01	640	1	days	TCGA-W5-AA2O	640	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			57	3.5	4.1	5.0		TCGA-W5-AA2O	TCGA-W5-AA2O-01A	0.0	0.4	34	0	55		A	None	0.9	1.4	1.1	-21118	2771	640	0			0			0	6.0	3.5	0 - No Fibrosis	2014-5-23	MALE	167	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	210	0.8	1.2	NO		G3					YES		true	No	M0	N0	T1	Stage I	TCGA-W5-AA2O.EDB0DC9B-6D0C-4591-81CA-BECD1BC27983.pdf	AA2O	NO	WITH TUMOR	150	150	450	NO	NO	0.8	NO	NO	R0	Primary Tumor	01	Extended Lobectomy	6th	NO	YES	W5	0.3	Bile duct	None	A	DECEASED	73	2006	TCGA-W5-AA2O-01A-11D-A417-09	TCGA-W5-AA2O-01A-11D-A417-09	TCGA-W5-AA2O-01A-11D-A418-05	0e8deabe-78a0-4960-8dc0-1afb483f409d	0e8deabe-78a0-4960-8dc0-1afb483f409d	TCGA-W5-AA2O-01A-11D-A417-09	TCGA-W5-AA2O-01	TCGA-W5-AA2O-01A-11D-A416-01	TCGA-W5-AA2O-01A-11D-A416-01	TCGA-W5-AA2O-01	0e8deabe-78a0-4960-8dc0-1afb483f409d	TCGA-W5-AA2O-01	TCGA-W5-AA2O-01A-11D-A417-09	TCGA-W5-AA2O-01	0e8deabe-78a0-4960-8dc0-1afb483f409d	302D85AD-761B-486B-B85B-F5751C06C25C
TCGA-W5-AA2Q-01	0	TCGA-W5-AA2Q-01	50	0	days	TCGA-W5-AA2Q	50	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			68	3.4	3.7	4.7	TCGA-W5-AA2Q-F66605	TCGA-W5-AA2Q	TCGA-W5-AA2Q-01A	0.1	1.4	247	0	55	1	A	None	0.9	1.4	1.0	-25069	2626		0	50		0	Bone cancer	Mother	0	6.0	4.3	1,2 - Portal Fibrosis	2014-10-21	MALE	165	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	120	8.4	12.0	NO	YES	G2					NO		true	No	M0	N0	T2b	Stage II	TCGA-W5-AA2Q.ED7C4C0A-BBCE-4136-B95F-4E49DB17EEE3.pdf	AA2Q	NO	TUMOR FREE	174	150	450	NO	NO	9.3	NO	YES	R0	Primary Tumor	01	Extended Lobectomy	6th	NO	YES	W5	1.0	Bile duct	None	A	LIVING	67	2006	TCGA-W5-AA2Q-01A-11D-A417-09	TCGA-W5-AA2Q-01A-11D-A417-09	TCGA-W5-AA2Q-01A-11D-A418-05	60f80712-30c2-4026-9853-9733f641c05f	60f80712-30c2-4026-9853-9733f641c05f	TCGA-W5-AA2Q-01A-11D-A417-09	TCGA-W5-AA2Q-01	TCGA-W5-AA2Q-01A-11D-A416-01	TCGA-W5-AA2Q-01A-11D-A416-01	TCGA-W5-AA2Q-01	60f80712-30c2-4026-9853-9733f641c05f	TCGA-W5-AA2Q-01	TCGA-W5-AA2Q-01A-11D-A417-09	TCGA-W5-AA2Q-01	60f80712-30c2-4026-9853-9733f641c05f	D86931F8-7166-464C-98BB-0BFA21496CD0
TCGA-W5-AA2Q-11	0	TCGA-W5-AA2Q-11	50	0	days	TCGA-W5-AA2Q	50	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			68	3.4	3.7	4.7	TCGA-W5-AA2Q-F66605	TCGA-W5-AA2Q		0.1	1.4	247	0	55	1	A	None	0.9	1.4	1.0	-25069			0	50		0	Bone cancer	Mother	0	6.0	4.3	1,2 - Portal Fibrosis	2014-10-21	MALE	165	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES		8.4	12.0		YES	G2					NO			No	M0	N0	T2b	Stage II		AA2Q	NO	TUMOR FREE	174	150	450	NO	NO	9.3	NO	YES	R0	Solid Tissue Normal	11	Extended Lobectomy	6th	NO	YES	W5	1.0	Bile duct	None		LIVING	67	2006			TCGA-W5-AA2Q-11A-11D-A418-05	f86273ce-18c0-47f3-af69-2eac38089508	f86273ce-18c0-47f3-af69-2eac38089508		TCGA-W5-AA2Q-11				f86273ce-18c0-47f3-af69-2eac38089508	TCGA-W5-AA2Q-11			f86273ce-18c0-47f3-af69-2eac38089508	
TCGA-W5-AA2R-01	0	TCGA-W5-AA2R-01	1542	0	days	TCGA-W5-AA2R	1542	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			77	3.5	4.2	5.0	TCGA-W5-AA2R-F72737	TCGA-W5-AA2R	TCGA-W5-AA2R-01A	0.1	0.5	11	0	55	3	A	None	0.6	1.1	0.9	-28367	2542		0	1542		0	colon cancer|transitional cell cancer|colon cancer	Brother|Brother|Sister	0	6.0	3.6	0 - No Fibrosis	2015-11-23	FEMALE	158	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES		0.9	1.2	NO	NO	G3					NO		true	No	M0	N0	T1	Stage I	TCGA-W5-AA2R.153949E2-169E-4138-8D39-9EC9C61C7F3C.pdf	AA2R	NO	TUMOR FREE	272	150	450	NO	NO	0.8	NO	YES	R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	W5	1.0	Bile duct	None	A	LIVING	72	2006	TCGA-W5-AA2R-01A-11D-A417-09	TCGA-W5-AA2R-01A-11D-A417-09	TCGA-W5-AA2R-01A-11D-A418-05	d3b1d5c8-a823-4630-a160-599bc0d5fb9a	d3b1d5c8-a823-4630-a160-599bc0d5fb9a	TCGA-W5-AA2R-01A-11D-A417-09	TCGA-W5-AA2R-01	TCGA-W5-AA2R-01A-11D-A416-01	TCGA-W5-AA2R-01A-11D-A416-01	TCGA-W5-AA2R-01	d3b1d5c8-a823-4630-a160-599bc0d5fb9a	TCGA-W5-AA2R-01	TCGA-W5-AA2R-01A-11D-A417-09	TCGA-W5-AA2R-01	d3b1d5c8-a823-4630-a160-599bc0d5fb9a	F6AEF1B0-C13B-4B98-B36F-88A5C6AE06F1
TCGA-W5-AA2R-11	0	TCGA-W5-AA2R-11	1542	0	days	TCGA-W5-AA2R	1542	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			77	3.5	4.2	5.0	TCGA-W5-AA2R-F72737	TCGA-W5-AA2R	TCGA-W5-AA2R-11A	0.1	0.5	11	0	55	3	A	None	0.6	1.1	0.9	-28367	2542		0	1542		0	colon cancer|transitional cell cancer|colon cancer	Brother|Brother|Sister	0	6.0	3.6	0 - No Fibrosis	2015-11-23	FEMALE	158	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	220	0.9	1.2	NO	NO	G3					NO		true	No	M0	N0	T1	Stage I		AA2R	NO	TUMOR FREE	272	150	450	NO	NO	0.8	NO	YES	R0	Solid Tissue Normal	11	Segmentectomy, Multiple	6th	NO	YES	W5	1.0	Bile duct	None	A	LIVING	72	2006			TCGA-W5-AA2R-11A-11D-A418-05	2649a2ec-8bb0-486e-9eec-ac9c76021b60	2649a2ec-8bb0-486e-9eec-ac9c76021b60		TCGA-W5-AA2R-11				2649a2ec-8bb0-486e-9eec-ac9c76021b60	TCGA-W5-AA2R-11			2649a2ec-8bb0-486e-9eec-ac9c76021b60	
TCGA-W5-AA2T-01	1	TCGA-W5-AA2T-01	1220	1	days	TCGA-W5-AA2T	1220	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			64	3.5	4.4	5.0		TCGA-W5-AA2T		0.1	0.4	33	0	55		A	None	0.6	1.1	0.6	-23560		1220	0			0						0 - No Fibrosis	2014-5-24	FEMALE	155	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES		0.8	1.2			G3					YES			Yes	M0	N0	T2	Stage II		AA2T	NO	WITH TUMOR	274	150	450	NO	YES	1.0	NO	NO	R0	Primary Tumor	01	Extended Lobectomy	6th	NO	YES	W5	1.0	Bile duct	None		DECEASED	62	2008	TCGA-W5-AA2T-01A-12D-A417-09	TCGA-W5-AA2T-01A-12D-A417-09	TCGA-W5-AA2T-01A-12D-A418-05	d6580402-f691-479a-8b3c-582547b22b0c	d6580402-f691-479a-8b3c-582547b22b0c	TCGA-W5-AA2T-01A-12D-A417-09	TCGA-W5-AA2T-01	TCGA-W5-AA2T-01A-12D-A416-01	TCGA-W5-AA2T-01A-12D-A416-01	TCGA-W5-AA2T-01	d6580402-f691-479a-8b3c-582547b22b0c	TCGA-W5-AA2T-01	TCGA-W5-AA2T-01A-12D-A417-09	TCGA-W5-AA2T-01	d6580402-f691-479a-8b3c-582547b22b0c	
TCGA-W5-AA2U-01	1	TCGA-W5-AA2U-01	627	1	days	TCGA-W5-AA2U	627	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			78	3.5	4.5	5.0		TCGA-W5-AA2U	TCGA-W5-AA2U-01A	0.1	0.7	91	0	55	1	A	None	0.6	1.1	0.8	-28552	1430	627	0			1		Sister				0 - No Fibrosis	2014-5-24	FEMALE	156	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	120	0.9	1.2	NO		G3					YES		true	No	M0	N0	T1	Stage I	TCGA-W5-AA2U.205BDA9B-D391-4075-B1A6-32CBF06B06EF.pdf	AA2U	NO	WITH TUMOR	305	150	450	NO	NO	1.0	NO	YES	R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	W5	1.0	Bile duct	None	A	DECEASED	60	2010	TCGA-W5-AA2U-01A-11D-A417-09	TCGA-W5-AA2U-01A-11D-A417-09	TCGA-W5-AA2U-01A-11D-A418-05	41df36db-590f-4410-8d1d-b9afbbc9cecc	41df36db-590f-4410-8d1d-b9afbbc9cecc	TCGA-W5-AA2U-01A-11D-A417-09	TCGA-W5-AA2U-01	TCGA-W5-AA2U-01A-11D-A416-01	TCGA-W5-AA2U-01A-11D-A416-01	TCGA-W5-AA2U-01	41df36db-590f-4410-8d1d-b9afbbc9cecc	TCGA-W5-AA2U-01	TCGA-W5-AA2U-01A-11D-A417-09	TCGA-W5-AA2U-01	41df36db-590f-4410-8d1d-b9afbbc9cecc	2C55FA24-21FD-4B4A-9703-9FF914C7276C
TCGA-W5-AA2U-11	1	TCGA-W5-AA2U-11	627	1	days	TCGA-W5-AA2U	627	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			78	3.5	4.5	5.0		TCGA-W5-AA2U		0.1	0.7	91	0	55	1	A	None	0.6	1.1	0.8	-28552		627	0			1		Sister				0 - No Fibrosis	2014-5-24	FEMALE	156	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES		0.9	1.2			G3					YES			No	M0	N0	T1	Stage I		AA2U	NO	WITH TUMOR	305	150	450	NO	NO	1.0	NO	YES	R0	Solid Tissue Normal	11	Segmentectomy, Multiple	7th	NO	YES	W5	1.0	Bile duct	None		DECEASED	60	2010			TCGA-W5-AA2U-11A-11D-A418-05	a59098ee-abee-46cc-af4a-cca9d501daec	a59098ee-abee-46cc-af4a-cca9d501daec		TCGA-W5-AA2U-11				a59098ee-abee-46cc-af4a-cca9d501daec	TCGA-W5-AA2U-11			a59098ee-abee-46cc-af4a-cca9d501daec	
TCGA-W5-AA2W-01	1	TCGA-W5-AA2W-01	924	1	days	TCGA-W5-AA2W	924	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			31	3.5	3.7	5.0		TCGA-W5-AA2W	TCGA-W5-AA2W-01A	0.1	0.4	104	0	55		A	None	0.6	1.1	0.6	-11438	1314	924	0			0						0 - No Fibrosis	2014-5-24	FEMALE	167	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	160	0.9	1.2	NO		G3					YES		true	No	M0	N1	T2a	Stage IVA	TCGA-W5-AA2W.EB47A378-F3DA-4892-8126-99CEE6BFA8EE.pdf	AA2W	NO	WITH TUMOR	217	150	450	NO	NO	1.1	NO	NO	R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	W5	1.0	Bile duct	None	A	DECEASED	91	2010	TCGA-W5-AA2W-01A-11D-A417-09	TCGA-W5-AA2W-01A-11D-A417-09	TCGA-W5-AA2W-01A-11D-A418-05	6fcc3918-f4b0-42ab-b00c-027175606cbd	6fcc3918-f4b0-42ab-b00c-027175606cbd	TCGA-W5-AA2W-01A-11D-A417-09	TCGA-W5-AA2W-01	TCGA-W5-AA2W-01A-11D-A416-01	TCGA-W5-AA2W-01A-11D-A416-01	TCGA-W5-AA2W-01	6fcc3918-f4b0-42ab-b00c-027175606cbd	TCGA-W5-AA2W-01	TCGA-W5-AA2W-01A-11D-A417-09	TCGA-W5-AA2W-01	6fcc3918-f4b0-42ab-b00c-027175606cbd	3D6C2B3C-A94D-4593-B040-F9C09695401B
TCGA-W5-AA2X-01	1	TCGA-W5-AA2X-01	271	1	days	TCGA-W5-AA2X	271	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			67	3.5	4.0	5.0		TCGA-W5-AA2X	TCGA-W5-AA2X-01A	0.1	0.7	203	0	55	1	A	None	0.8	1.3	0.8	-24797	1238	271	0			0	breast	Sister	0	6.0	4.0	1,2 - Portal Fibrosis	2014-5-24	MALE	167	No History of Primary Risk Factors		Cholangiocarcinoma; hilar/perihilar	No	C24.0	8160/3	C24.0	YES	120	0.9	1.2	NO		G4							true	No	M1	N1	T2b	Stage IVB	TCGA-W5-AA2X.D2B18607-E16D-4570-9E96-5A7CBAFD79FC.pdf	AA2X	NO		541	150	450	NO	NO	1.0	NO	YES	RX	Primary Tumor	01	Pancreaticoduodenectomy (Whipple Resection)	7th	NO	YES	W5	1.0	Bile duct	Micro	A	DECEASED	88	2010	TCGA-W5-AA2X-01A-11D-A417-09	TCGA-W5-AA2X-01A-11D-A417-09	TCGA-W5-AA2X-01A-11D-A418-05	1d507dd2-bb72-4305-a858-68fccae00d5e	1d507dd2-bb72-4305-a858-68fccae00d5e	TCGA-W5-AA2X-01A-11D-A417-09	TCGA-W5-AA2X-01	TCGA-W5-AA2X-01A-11D-A416-01	TCGA-W5-AA2X-01A-11D-A416-01	TCGA-W5-AA2X-01	1d507dd2-bb72-4305-a858-68fccae00d5e	TCGA-W5-AA2X-01	TCGA-W5-AA2X-01A-11D-A417-09	TCGA-W5-AA2X-01	1d507dd2-bb72-4305-a858-68fccae00d5e	8D1E6CEA-D755-4076-A2E1-F6F81E7162FB
TCGA-W5-AA2X-11	1	TCGA-W5-AA2X-11	271	1	days	TCGA-W5-AA2X	271	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			67	3.5	4.0	5.0		TCGA-W5-AA2X		0.1	0.7	203	0	55	1	A	None	0.8	1.3	0.8	-24797		271	0			0	breast	Sister	0	6.0	4.0	1,2 - Portal Fibrosis	2014-5-24	MALE	167	No History of Primary Risk Factors		Cholangiocarcinoma; hilar/perihilar	No	C24.0	8160/3	C24.0	YES		0.9	1.2			G4								No	M1	N1	T2b	Stage IVB		AA2X	NO		541	150	450	NO	NO	1.0	NO	YES	RX	Solid Tissue Normal	11	Pancreaticoduodenectomy (Whipple Resection)	7th	NO	YES	W5	1.0	Bile duct	Micro		DECEASED	88	2010			TCGA-W5-AA2X-11A-11D-A418-05	a6369fb0-1ca6-4215-9f2b-f4e8647e6f5a	a6369fb0-1ca6-4215-9f2b-f4e8647e6f5a		TCGA-W5-AA2X-11				a6369fb0-1ca6-4215-9f2b-f4e8647e6f5a	TCGA-W5-AA2X-11			a6369fb0-1ca6-4215-9f2b-f4e8647e6f5a	
TCGA-W5-AA2Z-01	0	TCGA-W5-AA2Z-01	1614	0	days	TCGA-W5-AA2Z	1614	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			29	3.5	4.6	5.0	TCGA-W5-AA2Z-F72738	TCGA-W5-AA2Z	TCGA-W5-AA2Z-01A	0.1	0.5	495	0	55	1	A	None	0.6	1.1	0.8	-10659	1178		0	1614		0	breast cancer	Grandmother	0	6.0	1.6	1,2 - Portal Fibrosis	2015-11-23	FEMALE	162	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	120	0.9	1.2	NO	NO	G3							true	No	M0	N0	T2	Stage II	TCGA-W5-AA2Z.22F994D3-20A5-46CD-958F-2AAAB3F2D2EC.pdf	AA2Z	NO	WITH TUMOR	242	150	450	NO	YES	1.0	NO	YES	R1	Primary Tumor	01	Lobectomy	7th	NO	YES	W5	1.0	Bile duct	None	A	LIVING	82	2010	TCGA-W5-AA2Z-01A-11D-A417-09	TCGA-W5-AA2Z-01A-11D-A417-09	TCGA-W5-AA2Z-01A-11D-A418-05	df40ecd0-42b7-45be-9789-098cc3c85f34	df40ecd0-42b7-45be-9789-098cc3c85f34	TCGA-W5-AA2Z-01A-11D-A417-09	TCGA-W5-AA2Z-01	TCGA-W5-AA2Z-01A-11D-A416-01	TCGA-W5-AA2Z-01A-11D-A416-01	TCGA-W5-AA2Z-01	df40ecd0-42b7-45be-9789-098cc3c85f34	TCGA-W5-AA2Z-01	TCGA-W5-AA2Z-01A-11D-A417-09	TCGA-W5-AA2Z-01	df40ecd0-42b7-45be-9789-098cc3c85f34	165A72AC-663B-4748-B047-C1E46CCB41FF
TCGA-W5-AA30-01	0	TCGA-W5-AA30-01	1153	0	days	TCGA-W5-AA30	1153	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			82	3.5	4.3	5.0	TCGA-W5-AA30-F72739	TCGA-W5-AA30	TCGA-W5-AA30-01A	0.1	0.9	265	0	55	1		None	0.8	1.3	1.0	-30039	1134		0	1153		0	colon cancer	Brother	0	6.0	3.7	0 - No Fibrosis	2015-11-23	MALE	188	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	200	0.8	1.2	NO	NO	G3					NO		true	No	M0	N0	T1	Stage I	TCGA-W5-AA30.9C2BEED7-DB8C-4BFE-920A-DD716B884777.pdf	AA30	NO	TUMOR FREE	134	150	450	NO	NO	1.0	NO	YES	R0	Primary Tumor	01	Lobectomy	7th	NO	YES	W5	1.0	Bile duct	None	A	LIVING	102	2010	TCGA-W5-AA30-01A-31D-A417-09	TCGA-W5-AA30-01A-31D-A417-09	TCGA-W5-AA30-01A-31D-A418-05	f53d3bb4-4d10-4321-b41b-87fed60e6fc1	f53d3bb4-4d10-4321-b41b-87fed60e6fc1	TCGA-W5-AA30-01A-31D-A417-09	TCGA-W5-AA30-01	TCGA-W5-AA30-01A-31D-A416-01	TCGA-W5-AA30-01A-31D-A416-01	TCGA-W5-AA30-01	f53d3bb4-4d10-4321-b41b-87fed60e6fc1	TCGA-W5-AA30-01	TCGA-W5-AA30-01A-31D-A417-09	TCGA-W5-AA30-01	f53d3bb4-4d10-4321-b41b-87fed60e6fc1	9C4BC985-43F5-421E-A479-3CFD9AE12506
TCGA-W5-AA30-11	0	TCGA-W5-AA30-11	1153	0	days	TCGA-W5-AA30	1153	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			82	3.5	4.3	5.0	TCGA-W5-AA30-F72739	TCGA-W5-AA30		0.1	0.9	265	0	55	1		None	0.8	1.3	1.0	-30039			0	1153		0	colon cancer	Brother	0	6.0	3.7	0 - No Fibrosis	2015-11-23	MALE	188	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES		0.8	1.2		NO	G3					NO			No	M0	N0	T1	Stage I		AA30	NO	TUMOR FREE	134	150	450	NO	NO	1.0	NO	YES	R0	Solid Tissue Normal	11	Lobectomy	7th	NO	YES	W5	1.0	Bile duct	None		LIVING	102	2010			TCGA-W5-AA30-11A-11D-A418-05	e819d2ae-9cfb-4256-a15c-23fbb3683ee7	e819d2ae-9cfb-4256-a15c-23fbb3683ee7		TCGA-W5-AA30-11				e819d2ae-9cfb-4256-a15c-23fbb3683ee7	TCGA-W5-AA30-11			e819d2ae-9cfb-4256-a15c-23fbb3683ee7	
TCGA-W5-AA31-01	0	TCGA-W5-AA31-01	10	0	days	TCGA-W5-AA31	10	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			71				TCGA-W5-AA31-F66611	TCGA-W5-AA31	TCGA-W5-AA31-01A	0.1	0.6	18	0	55	2		None	0.8	1.3	0.9	-26139	1079		0	10		0	Gastric Cancer|Testicular Cancer	Sister|Child	0	6.0	4.4	0 - No Fibrosis	2014-10-21	MALE	184	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	180	0.9	1.2	NO	YES	G3					NO		true	Yes	M0	N0	T1	Stage I	TCGA-W5-AA31.A3B869CE-5B61-4F3E-930E-BC6CB37DD4F0.pdf	AA31	NO	TUMOR FREE	151	150	450	NO	NO	1.1	NO	YES	R0	Primary Tumor	01	Extended Lobectomy	7th	NO	YES	W5	1.1	Bile duct	None	A	LIVING	105	2010	TCGA-W5-AA31-01A-11D-A417-09	TCGA-W5-AA31-01A-11D-A417-09	TCGA-W5-AA31-01A-11D-A418-05	b4468779-3068-40d2-809c-7b513d0a752f	b4468779-3068-40d2-809c-7b513d0a752f	TCGA-W5-AA31-01A-11D-A417-09	TCGA-W5-AA31-01	TCGA-W5-AA31-01A-11D-A416-01	TCGA-W5-AA31-01A-11D-A416-01	TCGA-W5-AA31-01	b4468779-3068-40d2-809c-7b513d0a752f	TCGA-W5-AA31-01	TCGA-W5-AA31-01A-11D-A417-09	TCGA-W5-AA31-01	b4468779-3068-40d2-809c-7b513d0a752f	4D8A1449-67BD-4B03-BC47-29A5ECFD1FDB
TCGA-W5-AA31-11	0	TCGA-W5-AA31-11	10	0	days	TCGA-W5-AA31	10	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			71				TCGA-W5-AA31-F66611	TCGA-W5-AA31	TCGA-W5-AA31-11A	0.1	0.6	18	0	55	2		None	0.8	1.3	0.9	-26139	1079		0	10		0	Gastric Cancer|Testicular Cancer	Sister|Child	0	6.0	4.4	0 - No Fibrosis	2014-10-21	MALE	184	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	150	0.9	1.2	NO	YES	G3					NO		true	Yes	M0	N0	T1	Stage I		AA31	NO	TUMOR FREE	151	150	450	NO	NO	1.1	NO	YES	R0	Solid Tissue Normal	11	Extended Lobectomy	7th	NO	YES	W5	1.1	Bile duct	None	A	LIVING	105	2010			TCGA-W5-AA31-11A-11D-A418-05	699c7545-9b63-4b7d-9f65-fc538ac31ff3	699c7545-9b63-4b7d-9f65-fc538ac31ff3		TCGA-W5-AA31-11				699c7545-9b63-4b7d-9f65-fc538ac31ff3	TCGA-W5-AA31-11			699c7545-9b63-4b7d-9f65-fc538ac31ff3	
TCGA-W5-AA33-01	0	TCGA-W5-AA33-01	1449	0	days	TCGA-W5-AA33	1449	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			60	3.5	4.4	5.0	TCGA-W5-AA33-F72740	TCGA-W5-AA33	TCGA-W5-AA33-01A	0.1	0.5	17	0	55	2	A	None	0.8	1.3	1.0	-22090	959		0	1449		1	Prostate Cancer|Breast Cancer and skin cancer	Father|Grandmother	0	6.0	2.0	0 - No Fibrosis	2015-11-23	MALE	192	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	170	0.8	1.2	NO	NO	G3					NO		true	No	M0	N0	T1	Stage I	TCGA-W5-AA33.FAB26B40-D86E-4937-9D4D-2473D2AA838F.pdf	AA33	NO	TUMOR FREE	231	150	450	NO	NO	1.1	NO	YES	R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	W5	1.0	Bile duct	None	A	LIVING	128	2011	TCGA-W5-AA33-01A-11D-A417-09	TCGA-W5-AA33-01A-11D-A417-09	TCGA-W5-AA33-01A-11D-A418-05	e67b53ac-771f-4b92-aad8-da78c97f4bcb	e67b53ac-771f-4b92-aad8-da78c97f4bcb	TCGA-W5-AA33-01A-11D-A417-09	TCGA-W5-AA33-01	TCGA-W5-AA33-01A-11D-A416-01	TCGA-W5-AA33-01A-11D-A416-01	TCGA-W5-AA33-01	e67b53ac-771f-4b92-aad8-da78c97f4bcb	TCGA-W5-AA33-01	TCGA-W5-AA33-01A-11D-A417-09	TCGA-W5-AA33-01	e67b53ac-771f-4b92-aad8-da78c97f4bcb	B5D126FD-6373-4859-A8A2-959DF66AAD29
TCGA-W5-AA34-01	1	TCGA-W5-AA34-01	555	1	days	TCGA-W5-AA34	555	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct	NO	NO	75	3.5	4.2	5.0	TCGA-W5-AA34-F66612	TCGA-W5-AA34	TCGA-W5-AA34-01A	0.1	0.4	25	0	55	4	A	None	0.6	1.1	0.6	-27535	461	555	0	168	40	1	Stomach cancer|Prostate and colon cancer|lung cancer|non-invasive ductal carcinoma in situ of the breast	Mother|Father|Sister|Sister	0	6.0	2.5	0 - No Fibrosis	2014-10-21	FEMALE	160	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	140	0.8	1.2	NO	NO	G2	Liver	Intrahepatic Recurrence	YES		YES	NO	true	No	M0	N0	T1	Stage I	TCGA-W5-AA34.36EAF28B-5091-4C1A-8BA6-D18C0407FC47.pdf	AA34	NO	WITH TUMOR	203	150	450	NO	NO	1.0	NO	YES	R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	W5	1.0	Bile duct	None	A	DECEASED	71	2012	TCGA-W5-AA34-01A-11D-A417-09	TCGA-W5-AA34-01A-11D-A417-09	TCGA-W5-AA34-01A-11D-A418-05	84e6718b-08c9-475d-906d-045e8f5477a0	84e6718b-08c9-475d-906d-045e8f5477a0	TCGA-W5-AA34-01A-11D-A417-09	TCGA-W5-AA34-01	TCGA-W5-AA34-01A-11D-A416-01	TCGA-W5-AA34-01A-11D-A416-01	TCGA-W5-AA34-01	84e6718b-08c9-475d-906d-045e8f5477a0	TCGA-W5-AA34-01	TCGA-W5-AA34-01A-11D-A417-09	TCGA-W5-AA34-01	84e6718b-08c9-475d-906d-045e8f5477a0	607DC467-8DB8-424B-BFDA-05AC7B83186B
TCGA-W5-AA34-11	1	TCGA-W5-AA34-11	555	1	days	TCGA-W5-AA34	555	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct	NO	NO	75	3.5	4.2	5.0	TCGA-W5-AA34-F66612	TCGA-W5-AA34	TCGA-W5-AA34-11A	0.1	0.4	25	0	55	4	A	None	0.6	1.1	0.6	-27535	461	555	0	168	40	1	Stomach cancer|Prostate and colon cancer|lung cancer|non-invasive ductal carcinoma in situ of the breast	Mother|Father|Sister|Sister	0	6.0	2.5	0 - No Fibrosis	2014-10-21	FEMALE	160	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	250	0.8	1.2	NO	NO	G2	Liver	Intrahepatic Recurrence	YES		YES	NO	true	No	M0	N0	T1	Stage I		AA34	NO	WITH TUMOR	203	150	450	NO	NO	1.0	NO	YES	R0	Solid Tissue Normal	11	Segmentectomy, Single	7th	NO	YES	W5	1.0	Bile duct	None	A	DECEASED	71	2012			TCGA-W5-AA34-11A-11D-A418-05	9d7ac93a-ca45-44ed-a326-5e404e0d3b85	9d7ac93a-ca45-44ed-a326-5e404e0d3b85		TCGA-W5-AA34-11				9d7ac93a-ca45-44ed-a326-5e404e0d3b85	TCGA-W5-AA34-11			9d7ac93a-ca45-44ed-a326-5e404e0d3b85	
TCGA-W5-AA36-01	1	TCGA-W5-AA36-01	1402	1	days	TCGA-W5-AA36	1402	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			51	3.5	4.6	5.0		TCGA-W5-AA36	TCGA-W5-AA36-01A	0.1	0.8	1	0	55		A	None	0.6	1.1	0.8	-18882	2007	1402	0			0			0	6	14	0 - No Fibrosis	2014-5-27	FEMALE	165	No History of Primary Risk Factors		Cholangiocarcinoma; hilar/perihilar	Yes	C22.1	8160/3	C22.1	YES	100	0.8	1.2	NO		G3					YES		true	No	M1	N0	T3	Stage IV	TCGA-W5-AA36.6EC57D32-953A-4B46-AF10-A3AFCF636ED4.pdf	AA36	NO	WITH TUMOR	197	150	450	NO	YES	1.3	NO		R0	Primary Tumor	01	Extended Lobectomy	6th	NO	YES	W5	1.0	Bile duct	None	A	DECEASED	68	2008	TCGA-W5-AA36-01A-11D-A417-09	TCGA-W5-AA36-01A-11D-A417-09	TCGA-W5-AA36-01A-11D-A418-05	b8dabef1-a207-4c40-bf80-d61ad7dbf571	b8dabef1-a207-4c40-bf80-d61ad7dbf571	TCGA-W5-AA36-01A-11D-A417-09	TCGA-W5-AA36-01	TCGA-W5-AA36-01A-11D-A416-01	TCGA-W5-AA36-01A-11D-A416-01	TCGA-W5-AA36-01	b8dabef1-a207-4c40-bf80-d61ad7dbf571	TCGA-W5-AA36-01	TCGA-W5-AA36-01A-11D-A417-09	TCGA-W5-AA36-01	b8dabef1-a207-4c40-bf80-d61ad7dbf571	75CAFA30-1E76-47C9-9ED2-392C23E5E1D7
TCGA-W5-AA38-01	0	TCGA-W5-AA38-01	1471	0	days	TCGA-W5-AA38	1471	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			55	3.5	4.8	5.0	TCGA-W5-AA38-F72741	TCGA-W5-AA38	TCGA-W5-AA38-01A	0.1	0.3	199	0	55	1	A	None	0.6	1.1	0.6	-20285	875		0	1471		1	colorectal cancer	Mother	0	6.0	2.2	1,2 - Portal Fibrosis	2015-11-23	FEMALE	168	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	150	0.8	1.2	NO	NO	G3					YES		true	No	M0	N0	T1	Stage I	TCGA-W5-AA38.626B6057-4EFB-4AC9-A761-6759D5EF9EC1.pdf	AA38	NO	TUMOR FREE	239	150	450	NO	NO	1.0	NO	YES	R0	Primary Tumor	01	Lobectomy	7th	NO	YES	W5	1.0	Bile duct	None	A	LIVING	73	2011	TCGA-W5-AA38-01A-11D-A417-09	TCGA-W5-AA38-01A-11D-A417-09	TCGA-W5-AA38-01A-11D-A418-05	cf410999-4cac-4f7b-9062-bfd807c50355	cf410999-4cac-4f7b-9062-bfd807c50355	TCGA-W5-AA38-01A-11D-A417-09	TCGA-W5-AA38-01	TCGA-W5-AA38-01A-11D-A416-01	TCGA-W5-AA38-01A-11D-A416-01	TCGA-W5-AA38-01	cf410999-4cac-4f7b-9062-bfd807c50355	TCGA-W5-AA38-01	TCGA-W5-AA38-01A-11D-A417-09	TCGA-W5-AA38-01	cf410999-4cac-4f7b-9062-bfd807c50355	851ABA0D-40A6-4D93-89B7-0D46180B1FE0
TCGA-W5-AA39-01	1	TCGA-W5-AA39-01	170	1	days	TCGA-W5-AA39	170	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			81	3.5	3.5	5.0		TCGA-W5-AA39	TCGA-W5-AA39-01A	0.1	0.6	57	0	55	2	A	None	0.8	1.3	1.1	-29594	1286	170	0			1	cervical cancer|lung cancer	Mother|Father	0	6.0	2.7	0 - No Fibrosis	2014-5-27	MALE	176	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	220	0.9	1.2	NO		G4							true	No	M0	N0	T2	Stage II	TCGA-W5-AA39.733CC9D1-7D35-4976-9CD9-B8B8542313E2.pdf	AA39	NO	WITH TUMOR	350	150	450	NO	NO	1.2	NO	YES	RX	Primary Tumor	01	Lobectomy	7th	NO	YES	W5	1.0	Bile duct	None	A	DECEASED	80	2010	TCGA-W5-AA39-01A-11D-A417-09	TCGA-W5-AA39-01A-11D-A417-09	TCGA-W5-AA39-01A-11D-A418-05	342a4721-d5b0-487f-a2a7-a8ef6b7a924c	342a4721-d5b0-487f-a2a7-a8ef6b7a924c	TCGA-W5-AA39-01A-11D-A417-09	TCGA-W5-AA39-01	TCGA-W5-AA39-01A-11D-A416-01	TCGA-W5-AA39-01A-11D-A416-01	TCGA-W5-AA39-01	342a4721-d5b0-487f-a2a7-a8ef6b7a924c	TCGA-W5-AA39-01	TCGA-W5-AA39-01A-11D-A417-09	TCGA-W5-AA39-01	342a4721-d5b0-487f-a2a7-a8ef6b7a924c	4B196223-A359-4F08-9BA2-BE0E00587E91
TCGA-W6-AA0S-01	0	TCGA-W6-AA0S-01	808	0	days	TCGA-W6-AA0S	808	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct		NO	46	3.5	4.0	4.8	TCGA-W6-AA0S-F67141	TCGA-W6-AA0S	TCGA-W6-AA0S-01A	0.2	0.3		0	36		A	None	0.5	1.0	0.6	-16951	235		0	808	549	0			0	8		1,2 - Portal Fibrosis	2015-11-24	FEMALE	144	Diabetes mellitus|Non-Alcoholic Fatty Liver Disease		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	210	0.9	1.2	NO	NO	G2	Non-regional / Distant Lymph Nodes	Extrahepatic Recurrence	NO	NO	NO	NO	true	No	MX	N0	T1	Stage I	TCGA-W6-AA0S.2F3CE1B3-0DFD-4729-8A52-5E0BDE92BD12.pdf	AA0S	YES	TUMOR FREE	267	140	450	NO	YES	1.0	NO	NO	R0	Primary Tumor	01	Extended Lobectomy	7th	YES	NO	W6	1.3	Bile duct	None	A	LIVING	61	2013	TCGA-W6-AA0S-01A-11D-A417-09	TCGA-W6-AA0S-01A-11D-A417-09	TCGA-W6-AA0S-01A-11D-A418-05	f5475a42-4520-4124-9ace-8c0ed9eabefb	f5475a42-4520-4124-9ace-8c0ed9eabefb	TCGA-W6-AA0S-01A-11D-A417-09	TCGA-W6-AA0S-01	TCGA-W6-AA0S-01A-11D-A416-01	TCGA-W6-AA0S-01A-11D-A416-01	TCGA-W6-AA0S-01	f5475a42-4520-4124-9ace-8c0ed9eabefb	TCGA-W6-AA0S-01	TCGA-W6-AA0S-01A-11D-A417-09	TCGA-W6-AA0S-01	f5475a42-4520-4124-9ace-8c0ed9eabefb	C97EF18D-DC2E-441E-B7CB-AB02A59B702A
TCGA-WD-A7RX-01	1	TCGA-WD-A7RX-01	21	1	days	TCGA-WD-A7RX	21	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			71	3.5	3.7	4.8		TCGA-WD-A7RX	TCGA-WD-A7RX-01A	0.3	0.6	34	0	37	1			0.40	1.00	0.9	-26006	86	21	0			0	multiple myeloma	Mother	0	8.1	2.6	3,4 - Fibrous Speta	2013-12-23	FEMALE	147	Cirrhosis|Diabetes mellitus|Smoking		Cholangiocarcinoma; intrahepatic	No	C22.0	8160/3	C22.0	YES	250	10.4	13.1	NO		G2					NO		true	No	MX	NX	T2b	Stage II	TCGA-WD-A7RX.9D3F4AEF-2F52-4035-AFFC-A5AD2A31EE5D.pdf	A7RX		TUMOR FREE	156	150	400	NO	NO	12.2	NO	YES	RX	Primary Tumor	01	Other (specify)	7th	YES	NO	WD	1.2	Bile duct	None	A	DECEASED	51	2013	TCGA-WD-A7RX-01A-12D-A417-09	TCGA-WD-A7RX-01A-12D-A417-09	TCGA-WD-A7RX-01A-12D-A418-05	015b2409-ca2e-4141-8266-fe619793761c	015b2409-ca2e-4141-8266-fe619793761c	TCGA-WD-A7RX-01A-12D-A417-09	TCGA-WD-A7RX-01	TCGA-WD-A7RX-01A-12D-A416-01	TCGA-WD-A7RX-01A-12D-A416-01	TCGA-WD-A7RX-01	015b2409-ca2e-4141-8266-fe619793761c	TCGA-WD-A7RX-01	TCGA-WD-A7RX-01A-12D-A417-09	TCGA-WD-A7RX-01	015b2409-ca2e-4141-8266-fe619793761c	168F37C1-CDC4-46FE-809C-B775ECEBD99C
TCGA-YR-A95A-01	1	TCGA-YR-A95A-01	26	1	days	TCGA-YR-A95A	26	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			52	3.4	4.3	4.8		TCGA-YR-A95A	TCGA-YR-A95A-01A		2	18.15	0	39				0.7	1.2	0.8	-19292	1589	26	0				Brain tumor	Sister	0	15	1.38		2014-10-23	MALE	177	No History of Primary Risk Factors		Cholangiocarcinoma; hilar/perihilar	No	C24.0	8160/3	C24.0	YES	130	0	1.2	NO		G2					YES		false	No	M1	NX	T2	Stage IV	TCGA-YR-A95A.AB615D8F-E4A3-48A9-86A3-C89861C89A5D.pdf	A95A	YES	WITH TUMOR	240000	125000	450000	NO	NO	0.9	NO	YES	R1	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	YR		Bile duct		A	DECEASED	77	2009	TCGA-YR-A95A-01A-12D-A417-09	TCGA-YR-A95A-01A-12D-A417-09	TCGA-YR-A95A-01A-12D-A418-05	7bb15e31-2b7d-4926-b78a-0d2aa7bddd78	7bb15e31-2b7d-4926-b78a-0d2aa7bddd78	TCGA-YR-A95A-01A-12D-A417-09	TCGA-YR-A95A-01	TCGA-YR-A95A-01A-12D-A416-01	TCGA-YR-A95A-01A-12D-A416-01	TCGA-YR-A95A-01	7bb15e31-2b7d-4926-b78a-0d2aa7bddd78	TCGA-YR-A95A-01	TCGA-YR-A95A-01A-12D-A417-09	TCGA-YR-A95A-01	7bb15e31-2b7d-4926-b78a-0d2aa7bddd78	C8B9157D-FDC5-44D4-852D-C231457D467E
TCGA-ZD-A8I3-01	1	TCGA-ZD-A8I3-01	169	1	days	TCGA-ZD-A8I3	169	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct	NO	NO	73				TCGA-ZD-A8I3-F69616	TCGA-ZD-A8I3	TCGA-ZD-A8I3-01A												-26754	173	169	0	0	59	3							2015-1-15	FEMALE	152	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	250			NO	NO	G3	Liver	Locoregional Recurrence	NO	NO	YES	NO	true	No	M0	N0	T2	Stage II	TCGA-ZD-A8I3.0A18D59B-0D93-409E-8E7F-156B1C77964B.pdf	A8I3		WITH TUMOR				NO	NO		NO	NO	R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ZD		Bile duct		A	DECEASED	49	2013	TCGA-ZD-A8I3-01A-11D-A417-09	TCGA-ZD-A8I3-01A-11D-A417-09	TCGA-ZD-A8I3-01A-11D-A418-05	be89bf4d-75f7-4596-9251-490976f7e254	be89bf4d-75f7-4596-9251-490976f7e254	TCGA-ZD-A8I3-01A-11D-A417-09	TCGA-ZD-A8I3-01	TCGA-ZD-A8I3-01A-11D-A416-01	TCGA-ZD-A8I3-01A-11D-A416-01	TCGA-ZD-A8I3-01	be89bf4d-75f7-4596-9251-490976f7e254	TCGA-ZD-A8I3-01	TCGA-ZD-A8I3-01A-11D-A417-09	TCGA-ZD-A8I3-01	be89bf4d-75f7-4596-9251-490976f7e254	CF371F36-D0C6-4371-9525-E0C0EBADF201
TCGA-ZH-A8Y1-01	1	TCGA-ZH-A8Y1-01	385	1	days	TCGA-ZH-A8Y1	385	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			74	3.5	4.6	5.0		TCGA-ZH-A8Y1	TCGA-ZH-A8Y1-01A	0.0	0.7	6910		55				0.6	1.0	0.8	-27279	426	385	0			1							2014-3-11	FEMALE	165	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	550			NO		G2					YES		false	Yes	M0	N1	T3	Stage IVA	TCGA-ZH-A8Y1.B4025F42-46CB-4D4E-ABB4-DBF701615F14.pdf	A8Y1		WITH TUMOR	272000	150000	440000	NO	NO	0.9	NO	NO	R1	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	ZH	1.2	Bile duct	Micro	A	DECEASED	78	2012	TCGA-ZH-A8Y1-01A-11D-A417-09	TCGA-ZH-A8Y1-01A-11D-A417-09	TCGA-ZH-A8Y1-01A-11D-A418-05	11aba6d6-271d-4d59-a2be-8cbd88a48d40	11aba6d6-271d-4d59-a2be-8cbd88a48d40	TCGA-ZH-A8Y1-01A-11D-A417-09	TCGA-ZH-A8Y1-01	TCGA-ZH-A8Y1-01A-11D-A416-01	TCGA-ZH-A8Y1-01A-11D-A416-01	TCGA-ZH-A8Y1-01	11aba6d6-271d-4d59-a2be-8cbd88a48d40	TCGA-ZH-A8Y1-01	TCGA-ZH-A8Y1-01A-11D-A417-09	TCGA-ZH-A8Y1-01	11aba6d6-271d-4d59-a2be-8cbd88a48d40	1D74BEBF-3581-4383-8009-EC2A10B36FE2
TCGA-ZH-A8Y2-01	1	TCGA-ZH-A8Y2-01	701	1	days	TCGA-ZH-A8Y2	701	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			59					TCGA-ZH-A8Y2	TCGA-ZH-A8Y2-01A						3						-21743	897	701	0				Colon	Sister|Sister|Brother	0.0	10.0	7.8		2014-3-11	FEMALE	173	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	400			NO		G2					YES		false	No	M0	NX	T1	Stage I	TCGA-ZH-A8Y2.1D1D2814-ECEE-463D-9EF9-E27F9CDCFEB6.pdf	A8Y2	NO	WITH TUMOR				NO	NO		NO	YES	R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	ZH		Bile duct	Micro	A	DECEASED	80	2011	TCGA-ZH-A8Y2-01A-11D-A417-09	TCGA-ZH-A8Y2-01A-11D-A417-09	TCGA-ZH-A8Y2-01A-11D-A418-05	63a3bd41-6a68-4eb5-ad4f-0fd05be97ac1	63a3bd41-6a68-4eb5-ad4f-0fd05be97ac1	TCGA-ZH-A8Y2-01A-11D-A417-09	TCGA-ZH-A8Y2-01	TCGA-ZH-A8Y2-01A-11D-A416-01	TCGA-ZH-A8Y2-01A-11D-A416-01	TCGA-ZH-A8Y2-01	63a3bd41-6a68-4eb5-ad4f-0fd05be97ac1	TCGA-ZH-A8Y2-01	TCGA-ZH-A8Y2-01A-11D-A417-09	TCGA-ZH-A8Y2-01	63a3bd41-6a68-4eb5-ad4f-0fd05be97ac1	A22CAEBD-B501-46FB-9DCE-BD22261601E5
TCGA-ZH-A8Y4-01	1	TCGA-ZH-A8Y4-01	741	1	days	TCGA-ZH-A8Y4	741	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			58	3.5	4.2	5.0		TCGA-ZH-A8Y4	TCGA-ZH-A8Y4-01A	0.0	0.3	27		55	1			0.7	1.3	0.9	-21503	1315	741	0				Melanoma	Mother	0.0	10.0	6.0		2014-3-11	MALE	183	Diabetes mellitus|Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	80			NO		G3					YES		false	Yes	M0	N0	T1	Stage I	TCGA-ZH-A8Y4.8C44AB5C-5F49-4F12-9273-F8AEDD9F0316.pdf	A8Y4	NO	WITH TUMOR	208000	150000	440000	NO	YES	1.1	NO	YES	R1	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	ZH	1.2	Bile duct	None	A	DECEASED	88	2010	TCGA-ZH-A8Y4-01A-11D-A417-09	TCGA-ZH-A8Y4-01A-11D-A417-09	TCGA-ZH-A8Y4-01A-11D-A418-05	012cd145-9f6c-4b79-b929-3f42f61e3dce	012cd145-9f6c-4b79-b929-3f42f61e3dce	TCGA-ZH-A8Y4-01A-11D-A417-09	TCGA-ZH-A8Y4-01	TCGA-ZH-A8Y4-01A-11D-A416-01	TCGA-ZH-A8Y4-01A-11D-A416-01	TCGA-ZH-A8Y4-01	012cd145-9f6c-4b79-b929-3f42f61e3dce	TCGA-ZH-A8Y4-01	TCGA-ZH-A8Y4-01A-11D-A417-09	TCGA-ZH-A8Y4-01	012cd145-9f6c-4b79-b929-3f42f61e3dce	
TCGA-ZH-A8Y5-01	0	TCGA-ZH-A8Y5-01	1229	0	days	TCGA-ZH-A8Y5	1229	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			69	3.5	4.3	5.0	TCGA-ZH-A8Y5-F72746	TCGA-ZH-A8Y5	TCGA-ZH-A8Y5-01A	0.0	0.7	7		55	1			0.7	1.3	1.0	-25268	622		0	1229		0	Breast	Sister					2015-11-20	MALE	175	Smoking		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	240			NO	NO	G3					YES		false	No	M1	N1	T3	Stage IVB	TCGA-ZH-A8Y5.793D6E81-1D43-4C8F-9490-F55217AF4E8E.pdf	A8Y5	NO	WITH TUMOR	269000	150000	440000	NO	YES	1.0	NO	YES	R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	ZH	1.2	Bile duct	Micro	A	LIVING	85	2012	TCGA-ZH-A8Y5-01A-11D-A417-09	TCGA-ZH-A8Y5-01A-11D-A417-09	TCGA-ZH-A8Y5-01A-11D-A418-05	f7f581cf-3c93-4eaf-9f10-299006f058ce	f7f581cf-3c93-4eaf-9f10-299006f058ce	TCGA-ZH-A8Y5-01A-11D-A417-09	TCGA-ZH-A8Y5-01	TCGA-ZH-A8Y5-01A-11D-A416-01	TCGA-ZH-A8Y5-01A-11D-A416-01	TCGA-ZH-A8Y5-01	f7f581cf-3c93-4eaf-9f10-299006f058ce	TCGA-ZH-A8Y5-01	TCGA-ZH-A8Y5-01A-11D-A417-09	TCGA-ZH-A8Y5-01	f7f581cf-3c93-4eaf-9f10-299006f058ce	EAE08C09-848E-4EC5-BC01-B22F80E82B80
TCGA-ZH-A8Y6-01	0	TCGA-ZH-A8Y6-01	519	0	days	TCGA-ZH-A8Y6	519	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			41	3.4	3.9	5.0	TCGA-ZH-A8Y6-F70052	TCGA-ZH-A8Y6	TCGA-ZH-A8Y6-01A	0.2	0.3	29	0	35	3			0.6	1.3	1.2	-14976	148		0	519			uterine|uterine|breast	Mother|Grandmother|Grandmother					2015-1-26	FEMALE	152	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	350			NO	NO	G2					NO		false	No	M0	N0	T1	Stage I	TCGA-ZH-A8Y6.1308ED5B-3B3F-4E9A-91D6-64507F549473.pdf	A8Y6	NO	TUMOR FREE	279000	130000	400000	NO	NO	1.0	NO	YES	R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	ZH	1.0	Bile duct	None	A	LIVING	89	2013	TCGA-ZH-A8Y6-01A-11D-A417-09	TCGA-ZH-A8Y6-01A-11D-A417-09	TCGA-ZH-A8Y6-01A-11D-A418-05	f322aedd-a561-4b14-b2e3-f60087b705f7	f322aedd-a561-4b14-b2e3-f60087b705f7	TCGA-ZH-A8Y6-01A-11D-A417-09	TCGA-ZH-A8Y6-01	TCGA-ZH-A8Y6-01A-11D-A416-01	TCGA-ZH-A8Y6-01A-11D-A416-01	TCGA-ZH-A8Y6-01	f322aedd-a561-4b14-b2e3-f60087b705f7	TCGA-ZH-A8Y6-01	TCGA-ZH-A8Y6-01A-11D-A417-09	TCGA-ZH-A8Y6-01	f322aedd-a561-4b14-b2e3-f60087b705f7	376510BA-DA10-4B45-ABFC-68AB37AB8408
TCGA-ZH-A8Y8-01	0	TCGA-ZH-A8Y8-01	602	0	days	TCGA-ZH-A8Y8	602	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			73				TCGA-ZH-A8Y8-F72747	TCGA-ZH-A8Y8	TCGA-ZH-A8Y8-01A	0.0	0.7	39.2	0.0	36.9	2			0.7	1.0	0.8	-26744	69		0	602			Thyroid|Lung	Sister|Sister					2015-11-24	MALE	183	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	390			NO	NO	G2					NO		false	Yes	M0	N0	T1	Stage I	TCGA-ZH-A8Y8.D35938C2-CFED-444E-8284-B1A4D5EAD0F3.pdf	A8Y8	YES	TUMOR FREE	261000	150000	440000	NO	NO	1.1	NO	YES	R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ZH	1.2	Bile duct	None	A	LIVING	98	2013	TCGA-ZH-A8Y8-01A-51D-A417-09	TCGA-ZH-A8Y8-01A-51D-A417-09	TCGA-ZH-A8Y8-01A-51D-A418-05	6d6c5a87-0773-418f-ae97-52e1cec8b8b1	6d6c5a87-0773-418f-ae97-52e1cec8b8b1	TCGA-ZH-A8Y8-01A-51D-A417-09	TCGA-ZH-A8Y8-01	TCGA-ZH-A8Y8-01A-51D-A416-01	TCGA-ZH-A8Y8-01A-51D-A416-01	TCGA-ZH-A8Y8-01	6d6c5a87-0773-418f-ae97-52e1cec8b8b1	TCGA-ZH-A8Y8-01	TCGA-ZH-A8Y8-01A-51D-A417-09	TCGA-ZH-A8Y8-01	6d6c5a87-0773-418f-ae97-52e1cec8b8b1	2FE6B28F-6DC8-45C3-AAC0-C83C46EDA9F0
TCGA-ZU-A8S4-01	1	TCGA-ZU-A8S4-01	98	1	days	TCGA-ZU-A8S4	98	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			52	3.5	4.2	5.0		TCGA-ZU-A8S4	TCGA-ZU-A8S4-01A	0.2	0.4	115	0	35.0				0.60	1.30	0.9	-19264	356	98	0						0	8.0	1.9	0 - No Fibrosis	2014-4-8	MALE	183	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES	70	0.9	1.2	NO		G3					YES		false	No	MX	NX	T1	Stage I	TCGA-ZU-A8S4.92337E74-DF14-48C7-90AC-907A787E1D0E.pdf	A8S4	YES	WITH TUMOR	279	140	400	NO	YES	1.1	NO	NO	R0	Primary Tumor	01	Lobectomy	7th	NO	YES	ZU	1.0	Bile duct	None	A	DECEASED	122	2012	TCGA-ZU-A8S4-01A-11D-A417-09	TCGA-ZU-A8S4-01A-11D-A417-09	TCGA-ZU-A8S4-01A-11D-A418-05	5cd9444b-4c4c-489a-b491-583da5510c80	5cd9444b-4c4c-489a-b491-583da5510c80	TCGA-ZU-A8S4-01A-11D-A417-09	TCGA-ZU-A8S4-01	TCGA-ZU-A8S4-01A-11D-A416-01	TCGA-ZU-A8S4-01A-11D-A416-01	TCGA-ZU-A8S4-01	5cd9444b-4c4c-489a-b491-583da5510c80	TCGA-ZU-A8S4-01	TCGA-ZU-A8S4-01A-11D-A417-09	TCGA-ZU-A8S4-01	5cd9444b-4c4c-489a-b491-583da5510c80	
TCGA-ZU-A8S4-11	1	TCGA-ZU-A8S4-11	98	1	days	TCGA-ZU-A8S4	98	days	TCGA Bile Duct Cancer (CHOL)	cholangiocarcinoma	Bile duct			52	3.5	4.2	5.0		TCGA-ZU-A8S4		0.2	0.4	115	0	35.0				0.60	1.30	0.9	-19264		98	0						0	8.0	1.9	0 - No Fibrosis	2014-4-8	MALE	183	No History of Primary Risk Factors		Cholangiocarcinoma; intrahepatic	No	C22.1	8160/3	C22.1	YES		0.9	1.2			G3					YES			No	MX	NX	T1	Stage I		A8S4	YES	WITH TUMOR	279	140	400	NO	YES	1.1	NO	NO	R0	Solid Tissue Normal	11	Lobectomy	7th	NO	YES	ZU	1.0	Bile duct	None		DECEASED	122	2012			TCGA-ZU-A8S4-11A-11D-A418-05	bd5dc5da-bd55-45d8-a045-93d99b737f0a	bd5dc5da-bd55-45d8-a045-93d99b737f0a		TCGA-ZU-A8S4-11				bd5dc5da-bd55-45d8-a045-93d99b737f0a	TCGA-ZU-A8S4-11			bd5dc5da-bd55-45d8-a045-93d99b737f0a	
